Papers

1

Total Citations

52

H-Index

1

About

Matthew Liew is a prominent urological researcher whose work centers on advancing treatment paradigms for clinically localized prostate cancer, with a particular focus on focal ablative therapy. His major contribution lies in critically evaluating the evidence base for emerging, less invasive treatments against standard management options. In his highly cited 2021 systematic review, Liew systematically dissected the limitations of available data on focal therapy, providing essential recommendations that bridge clinical practice and future research directions. This work, garnering 52 citations, has become a foundational reference for clinicians and researchers navigating the complexities of prostate cancer management. By highlighting gaps in evidence and advocating for rigorous comparative studies, Liew has shaped the discourse on personalized, organ-sparing approaches. His analysis underscores a commitment to evidence-based medicine, ensuring that innovation in urological oncology is matched by methodological rigor. For students and researchers, Liew’s work exemplifies how systematic reviews can drive clinical progress, offering a clear roadmap for improving patient outcomes through careful evaluation of emerging technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
52 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Wrightington, Wigan and Leigh NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago